ArticleJournal of the American Heart Association2023

Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials.

Robert A Fletcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.